Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus

Viral Immunology

Volumn 18, Issue 2, 2005, Pages 255-266

  Takimoto, Toru ^c   Hurwitz, Julia L ^a,b   Zhan, Xiaoyan ^a,b   Krishnamurthy, Sateesh ^a,b   Prouser, Cecilia ^a,b   Brown, Brita ^a,b   Coleclough, Chris ^a,b   Boyd, Kelli ^a,b   Scroggs, Ruth A ^a,b   Portner, Allen ^a,b   Slobod, Karen S ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MEASLES VACCINE; SMALLPOX VACCINE; VIRUS ANTIGEN; VIRUS VECTOR;

B LYMPHOCYTE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PARAINFLUENZA VIRUS 1; PARAMYXOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SENDAI VIRUS; T LYMPHOCYTE; VIRUS RECOMBINANT;

ANIMALS; CHILD; GENETIC VECTORS; HISTORY, 21ST CENTURY; HUMANS; MICE; RECOMBINATION, GENETIC; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SENDAI VIRUS; VACCINES, SYNTHETIC;

ANIMALIA; HUMAN PARAINFLUENZA VIRUS 1; MURINAE; PARAMYXOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SENDAI VIRUS;

EID: 23344436131     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2005.18.255     Document Type: Review

References (67)

1. Anderson, L.J., R.A. Parker, R.L. Strikas. 1990. Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. J. Infect. Dis. 161:640-646.
2. Anderson, M.J., J.R. Pattison, R.J. Cureton, et al. 1980. The role of host responses in the recovery of mice from Sendai virus infection. J. Gen. Virol. 46:373-379.
3. Chanock, R.M., B.R. Murphy, P.L. Collins. 2001. Parainfluenza viruses. In: Field's Virology. Lippincott Williams & Wilkins, Philadelphia, pp. 1341-1379.
4. Chin, J., R.L. Magoffin, L.A. Shearer, et al. 1969. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449-463.
5. Collins, P.L., R.M. Chanock, K. McIntosh. 1996. Parainfluenza virus. In: Field's Virology. B.N. Fields, D.M. Knipe, P.M. Howley (eds.). Lippincott Williams & Wilkins, Philadelphia, pp. 1205-1241.
6. Collins, P.L., R.M. Chanock, B.R. Murphy. 2001. Respiratory Syncytial Virus. In: Field's Virology. B.N. Fields, D.M. Knipe, P.M. Howley (eds.). Lippincott Williams & Wilkins, Philadelphia, pp. 1443-1485.
7. Connors, M., P.L. Collins, C.Y. Firestone, B.R. Murphy. 1991. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J. Virol. 65:1634-1637.
8. Crowe, J.E., Jr. 1996. The role of antibodies in respiratory viral immunity. Semin. Virol. 7:273-283.
9. Crowe, J.E., Jr. 1995. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development. Vaccine 13:415-421.
10. Dave, V.P., J.E. Allan, K.S. Slobod, et al. 1994. Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells. Virology 199:376-383.
11. de Waal, L.P., W.M. Kast, R.W., Melvold, C.J. Melief. 1983. Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants. J. Immunol. 130:1090-1096.
12. Feldman, S.A., R.M. Hendry, J.A. Beeler. 1999. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J. Virol. 73:6610-6617.
13. Friedewald, W.T., B.R. Forsyth, C.B. Smith, et al. 1968. Low-temperature-grown RS virus in adult volunteers. JAMA 203:690-694.
14. Fulginiti, V.A., J.J. Eller, O.F. Sieber, et al. 1969. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89:435-448.
15. Glezen, W.P., A.L. Frank, L.H. Taber, J.A. Kasel. 1984. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J. Infect. Dis. 150:851-857.
16. Glezen, W.P., A. Paredes, J.E. Allison, et al. 1981. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J. Pediatr. 98:708-715.
17. Gorman, W.L., D.S. Gill, R.A. Scroggs, A. Portner. 1990. The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity. Virology 175:211-221.
18. Groothuis, J.R., E.A. Simoes, M.J. Levin, et al. 1993. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N. Engl. J. Med. 329:1524-1530.
19. Haller, A.A., T. Miller, M. Mitiku, K. Coelingh. 2000. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. J. Virol. 74:11626-11635.
20. Heilman, C. A. 1990. From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses. J. Infect. Dis. 161:402-406.
21. Hou, S., P.C. Doherty, M. Zijlstra, et al. 1992. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J. Immunol. 149:1319-1325.
22. Hurwitz, J.L., K.F. Soike, M.Y. Sangster, et al. 1997. Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine 15:533-540.
23. Hyland, L., M. Sangster, R. Sealy, C. Coleclough. 1994. Respiratory virus infection of mice provokes a permanent humoral immune response. J. Virol. 68:6083-6086.
24. Iida, T., M. Tajima, Y. Murata. 1973. Transmission of maternal antibodies to Sendai virus in mice and its significance in enzootic infection. J. Gen. Virol. 18:247-254.
25. Ishida, N., M. Homma. 1978. Sendai virus. Adv. Virus Res. 23:349-383.
26. Janeway, C.A., P. Travers, M. Walport, M. Shlomchik. 2001. Immunobiology, the Immune System in Health and Disease. Garland Publishing, New York.
27. Kahn, J.S., M.J. Schnell, L. Buonocore, J.K. Rose. 1999. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology 254:81-91.
28. Karron, R.A., P.P. Wright, J.E. Crowe, et al. 1997. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J. Infect. Dis. 176: 1428-1436.
29. Karron, R.A., P.P. Wright, S.L. Hall, et al. 1995. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J. Infect. Dis. 171:1107-1114.
30. Kasel, J.A., E.E. Walsh, A.L. Frank, et al. 1987. Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children. Viral Immunol. 1:199-205.
31. Kast, W.M., Roux, L., Curren, J., et al. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. U.S.A. 88:2283-2287.
32. Kato, A., Y. Sakai, T. Shioda, et al. 1996. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1:569-579.
33. Kim, H.W., J.O. Arrobio, G. Pyles, et al. 1971. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics 48:745-755.
34. Kim, H.W., J.G. Canchola, C.D. Brandt, et al. 1969. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:422-434.
35. Kim, H.W., S.L. Leikin, J. Arrobio, et al. 1976. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr. Res. 10:75-78.
36. Kneyber, M.C., H.A. Moll, R. de Groot. 2000. Treatment and prevention of respiratory syncytial virus infection. Eur. J. Pediatr. 159:399-411.
37. Lamb, R.A., D. Kolakofsky. 2001. Paramyxoviridae: The viruses and their replication. In: Field's Virology. D.M. Knipe, P.M. Howley (eds.). Lippincott Williams & Wilkins, Philadelphia, pp. 1305-1340.
38. Lyn, D., D.S. Gill, R.A. Scroggs, A. Portner. 1991. The nucleoproteins of human parainfluenza virus type 1 and Sendai virus share amino acid sequences and antigenic and structural determinants. J. Gen. Virol. 72:983-987.
39. Merson, J.R., R.A. Hull, M.K. Estes, J.A. Kasel. 1988. Molecular cloning and sequence determination of the fusion protein gene of human parainfluenza virus type 1. Virology 167:97-105.
40. Murphy, B.R., S.L. Hall, A.B. Kulkarni, et al. 1994. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 32:13-36.
41. Murphy, B.R., G.A. Prince, E.E. Walsh, et al. 1986. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J. Clin. Microbiol. 24:197-202.
42. Norrby, E., J. Kovamees, M. Blixenkrone-Moller, et al. 1992. Humanized animal viruses with special reference to the primate adaptation of morbillivirus. Vet. Microbiol. 33:275-286.
43. Ogilvie, M.M., A.S. Vathenen, M. Radford, et al. 1981. Maternal antibody and respiratory syncytial virus infection in infancy. J. Med. Virol. 7:263-271.
44. Ottolini, M.G., D.D. Porter, V.G. Hemming, G.A. Prince. 2000. Enhanced pulmonary pathology in cotton rats upon challenge after immunization with inactivated parainfluenza virus 3 vaccines. Viral Immunol. 13:231-236.
45. Power, U.F., K.W. Ryan, A. Portner. 1992. Sequence characterization and expression of the matrix protein gene of human parainfluenza virus type 1. Virology 191:947-952.
46. Power, U.F., K.W. Ryan, A. Portner. 1992. The P genes of human parainfluenza virus type 1 clinical isolates are polycistronic and microheterogeneous. Virology 189:340-343.
47. Prince, G.A., S.J. Curtis, K.C. Yim, D.D. Porter. 2001. Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine. J. Gen. Virol. 82:2881-2888.
48. Prince, G.A., V.G. Hemming, R.L. Horswood, R.M. Chanock. 1985. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 3:193-206.
49. Prince, G.A., A.B. Jenson, V.G. Hemming, et al. 1986. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J. Virol. 57:721-728.
50. Prince, G.A., J.P. Prieels, M. Slaoui, D.D. Porter. 1999. Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus). Lab. Invest. 79:1385-1392.
51. Sakai, Y., K. Kiyotani, M. Fukumura, et al. 1999. Accommodation of foreign genes into the Sendai virus genome: sizes of inserted genes and viral replication. FEBS Lett. 456:221-226.
52. Sangster, M., F.S. Smith, C. Coleclough, J.L. Hurwitz. 1995. Human parainfluenza virus type 1 immunization of infant mice protects from subsequent Sendai virus infection. Virology 212:13-19.
53. Schmidt, A.C., J.M. McAuliffe, A. Huang, et al. 2000. Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates. J. Virol. 74:8922-8929.
54. Shay, D.K., R.C. Holman, G.E. Roosevelt, et al. 2001. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis. 183:16-22.
55. Simoes, E.A. 1999. Respiratory syncytial virus infection. Lancet 354:847-852.
56. Slobod, K.S., J.L. Shenep, J. Lujan-Zilbermann, et al. 2004. Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults. Vaccine 22:3182-3186.
57. Smith, F.S., A. Portner, R.J. Leggiadro, et al. 1994. Age-related development of human memory T-helper and B-cell responses toward parainfluenza virus type-1. Virology 205:453-461.
58. Stark, J.E., R.B. Heath. 1967. The development of antibodies against Sendai virus in childhood. Arch. Gesamte Virusforsch. 20:438-444.
59. Tai, F.H., S. Chiu, C.C. Ma. 1967. Sero-epidemiologic studies of Sendai virus infection on Taiwan. Taiwan Yi. Xue. Hui. Za Zhi. 66:312-318.
60. Takimoto, T., T. Bousse, E.C. Coronel, et al. 1998. Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. J. Virol. 72:9747-9754.
61. Takimoto, T., T. Bousse, A. Portner. 2000. Molecular cloning and expression of human parainfluenza virus type 1 L gene. Virus Res. 70:45-53.
62. Takimoto, T., J.L. Hurwitz, C. Coleclough, et al. 2004. Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. J. Virol. 78:6043-6047.
63. Tang, R.S., M. MacPhail, J.H. Schickli, et al. 2004. Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys. J. Virol. 78:11198-11207.
64. Taylor, G., E.J. Stott, M. Bew, et al. 1984. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137-142.
65. Tosi, M.F., K.L. Gates. 1998. Immunologic and phagocytic responses to infection. In: Textbook of Pediatric Infectious Diseases. R.D. Feigen, J.D. Cherry (eds.). W.B. Saunders, Philadelphia, pp. 14-53.
66. Welliver, R., D.T. Wong, T.S. Choi, P.L. Ogra. 1982. Natural history of parainfluenza virus infection in childhood. J. Pediatr. 101:180-187.
67. Welliver, R.C., A. Kaul, P.L. Ogra. 1979. Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J. Pediatr. 94:370-375.